0001214659-18-000291.txt : 20180109 0001214659-18-000291.hdr.sgml : 20180109 20180109063457 ACCESSION NUMBER: 0001214659-18-000291 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180105 FILED AS OF DATE: 20180109 DATE AS OF CHANGE: 20180109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thompson David E. CENTRAL INDEX KEY: 0001484500 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34637 FILM NUMBER: 18517825 MAIL ADDRESS: STREET 1: C/O ANTHERA PHARMACEUTICALS, INC. STREET 2: 25801 INDUSTRIAL BOULEVARD, SUITE B CITY: HAYWARD STATE: CA ZIP: 94545 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anthera Pharmaceuticals Inc CENTRAL INDEX KEY: 0001316175 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201852016 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25801 INDUSTRIAL BOULEVARD, SUITE B CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 856-5600 MAIL ADDRESS: STREET 1: 25801 INDUSTRIAL BOULEVARD, SUITE B CITY: HAYWARD STATE: CA ZIP: 94545 4 1 marketforms-40679.xml PRIMARY DOCUMENT X0306 4 2018-01-05 0001316175 Anthera Pharmaceuticals Inc ANTH 0001484500 Thompson David E. 25801 INDUSTRIAL BLVD SUITE B HAYWARD CA 94545 true false false false Stock Option (right to buy) 1.65 2018-01-05 4 A false 84705 0 A 2028-01-05 Common Stock 84705 84705 D Stock Option (right to buy) 1.65 2018-01-05 4 A false 84705 0 A 2028-01-05 Common Stock 84705 84705 D This option is granted pursuant to the Company's director compensation program and is for fiscal year ending December 31, 2017. This option vests in 12 equal monthly installments. The vesting commencement date is April 27, 2017. This option is granted pursuant to the Company's director compensation program and is for fiscal year ending December 31, 2018. This option vests in 12 equal monthly installments. The vesting commencement date is commensurate with the grant date of January 5, 2018. /s/ May Liu by power of attorney 2018-01-09